Tuhina Neogi, MD, PhD

Professor, Medicine

Tuhina Neogi
650 Albany St Evans Biomed Research Ctr


I am a rheumatologist and epidemiologist whose research has focused primarily on risk factors for knee osteoarthritis and gout, pain mechanisms in knee osteoarthritis, as well as methodologic issues of relevance for rheumatic diseases. I have had continuous peer-reviewed foundation and NIH funding since 2003, and have over 190 peer-reviewed publications to date. I am the most recent past chair of the FDA Arthritis Advisory Committee, serve on the boards two international societies: Osteoarthritis Research Society International (OARSI) and Gout, Hyperuricemia, and Crystal-Associated Diseases Network (G-CAN), and on committees for the American College of Rheumatology (ACR) and International Association for the Study Pain (IASP), among others. My work has been recognized with the prestigious 2014 ACR Henry Kunkel Young Investigator Award for outstanding and promising independent contributions to rheumatology research (awarded to no more than one clinical researcher and/or one basic science researcher each year). I have also engaged in developing new classification criteria for a number of rheumatic diseases. In addition to research, clinical work, and teaching, one of my key roles is to mentor trainees and junior faculty in musculoskeletal disease-related research. To that end, I was awarded the 2016 Robert Dawson Evans Research Mentoring Award. I am also leading the new CTSI Research Career Support Program initiative, PRIME (Pathways to Research Independence and Mentoring Excellence), which aims to support early career mentored researchers to successfully transition to becoming independent researchers.

Expertise includes:
– Osteoarthritis: epidemiology; risk factors; mechanisms of osteoarthritis-related pain; the role of bone in the pathophysiology of osteoarthritis
– Gout: epidemiology; risk factors and triggers for gout attacks; management of gout; consequences of gout and hyperuricemia
– Classification criteria and outcome measures in rheumatic diseases.
– Novel methodology to address challenging epidemiologic issues

Other Positions

  • Chief, Rheumatology, Medicine, Boston Medical Center
  • Professor, Epidemiology, Boston University School of Public Health
  • Section Chief of Rheumatology, Rheumatology, Medicine, Boston University School of Medicine
  • Investigator, Framingham Heart Study
  • Member, Arthritis & Autoimmune Diseases Research Center, Boston University
  • Member, Evans Center for Interdisciplinary Biomedical Research, Boston University


  • University of Toronto, MD
  • Boston University School of Public Health, PhD
  • McMaster University, BS


  • Published on 9/3/2020

    Carlesso LC, Frey Law L, Wang N, Nevitt M, Lewis CE, Neogi T. The Association of Pain Sensitization and Conditioned Pain Modulation to Pain Patterns in Knee Osteoarthritis. Arthritis Care Res (Hoboken). 2020 Sep 03. PMID: 32882103.

    Read at: PubMed
  • Published on 9/1/2020

    Stamp LK, Chapman P, Frampton C, Duffull SB, Drake J, Zhang Y, Neogi T. Lack of effect of tart cherry concentrate dose on serum urate in people with gout. Rheumatology (Oxford). 2020 Sep 01; 59(9):2374-2380. PMID: 31891407.

    Read at: PubMed
  • Published on 8/27/2020

    Master H, Neogi T, Callahan LF, Nelson AE, LaValley M, Cleveland RJ, Golightly YM, Thoma LM, Zhang Y, Voinier D, Christiansen MB, Jakiela JT, Nevitt M, Lewis CE, Frey-Law LA, White DK. The association between walking speed from short- and standard-distance tests with the risk of all-cause mortality among adults with radiographic knee osteoarthritis: Data from three large United States cohort studies. Osteoarthritis Cartilage. 2020 Aug 27. PMID: 32861851.

    Read at: PubMed
  • Published on 8/13/2020

    Jagpal A, Rahn EJ, Mudano AS, Dalbeth N, Taylor W, Saag KG, Singh JA, Cavagna L, Uhlig T, Perez-Ruiz F, McCarthy G, Gerritsen M, Stamp L, Vazquez Mellado J, Lin C, Vargas-Santos AB, Louthrenoo W, Neogi T, Chen YH, Castelar-Pinheiro GDR, Gaffo A. Which factors predict discordance between a patient and physician on a gout flare? Rheumatology (Oxford). 2020 Aug 13. PMID: 32793971.

    Read at: PubMed
  • Published on 8/5/2020

    Ballal P, Sury M, Lu N, Duryea J, Zhang Y, Ratzlaff C, Neogi T. The relation of oral bisphosphonates to bone marrow lesion volume among women with osteoarthritis. Osteoarthritis Cartilage. 2020 Aug 05. PMID: 32768598.

    Read at: PubMed
  • Published on 8/2/2020

    Zeng L, Qasim A, Neogi T, Fitzgerald JD, Dalbeth N, Mikuls TR, Guyatt GH, Brignardello-Petersen R. Comparative efficacy and safety of pharmacological interventions in patients experiencing a gout flare: a systematic review and network meta-analysis. Arthritis Care Res (Hoboken). 2020 Aug 02. PMID: 32741131.

    Read at: PubMed
  • Published on 7/23/2020

    Collins JE, Neogi T, Losina E. Rapid Structural Disease Progression in Knee Osteoarthritis Reply to Letter to the Editor. Arthritis Care Res (Hoboken). 2020 Jul 23. PMID: 32702195.

    Read at: PubMed
  • Published on 7/23/2020

    FitzGerald J, Brignardello-Petersen R, Dalbeth N, Mikuls T, Neogi T, Guyatt G. Author's response to Letter. Arthritis Care Res (Hoboken). 2020 Jul 23. PMID: 32702200.

    Read at: PubMed
  • Published on 7/21/2020

    Heisler AC, Song J, Dunlop DD, Wohlfahrt A, Bingham CO, Bolster MB, Clauw DJ, Marder W, Phillips K, Neogi T, Lee YC. Association of Pain Centralization and Patient-Reported Pain in Active Rheumatoid Arthritis. Arthritis Care Res (Hoboken). 2020 Aug; 72(8):1122-1129. PMID: 31162824.

    Read at: PubMed
  • Published on 7/19/2020

    Heisler AC, Song J, Muhammad LN, Wohlfahrt A, Marder W, Bolster MB, Bingham CO, Clauw DJ, Dunlop DD, Neogi T, Lee YC. Association of Dysregulated Central Pain Processing and Response to Disease-Modifying Anti-Rheumatic Drug Therapy in Rheumatoid Arthritis. Arthritis Rheumatol. 2020 Jul 19. PMID: 32683800.

    Read at: PubMed

View 240 more publications: View full profile at BUMC

View all profiles